PMD - Psychemedics Inc Debt to Book Capitalization Ratio

Graphic logo of Psychemedics (PMD)

The investment potential of Psychemedics (PMD) is bolstered by the robotization of hair analysis, which eliminates human error. The ratio of attracted funds to book capitalization demonstrates leverage dynamics, with the indicator standing at 0.32. Business stability is ensured by testing drivers and port workers to secure logistics safety, as well as a strategy for B2B client retention through the digital optimization of laboratory processes.

Psychemedics - PMD Debts to Book Capitalization (period 07/04/2022 - 12/21/2024)
Flagship merchandise of Psychemedics Corp

Reducing debt risks is a priority in the fundamental analysis of Psychemedics (PMD). Stable cash flow from the mature hair analysis segment minimizes the business's reliance on external borrowings. This indicator compares total liabilities with the market value of capital, as reflected in the total debt-to-book capitalization ratio. This metric's trend captures the current investor reassessment of the credit load. The decline in this value confirms financial stability but may signal conservative capital management.

Who Psychemedics competes with

Debts to Book Capitalization A (Agilent Technologies)|questdiagnostics.com - Debts to Book Capitalization|Illumina (ILMN) - Debt to Book Capitalization Ratio|EXAS - Debt to Book Value Ratio|RVTY: Debts to Book Capitalization|BIO (Bio-Rad Corp) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Anbio Biotechnology|Debt to Book Capitalization Ratio soterahealth.com (SHC)|QuidelOrtho Corporation - Debt to Book Value|Debts to Book Value OPK (OPKO Health Inc)|Debt to Book Capitalization Ratio CDNA|Debts to Net Assets Maravai MRVI|Debts to Book Capitalization FLGT (Fulgent Genetics, Inc.)|LAB: Debts to Net Assets|Cytek Biosciences - Debt to Book Capitalization Ratio|OSUR (OraSure Technologies, Inc.) - Debts to Net Assets|Debt to Book Capitalization Ratio Exagen Inc XGN|Debts to Book Capitalization Ratio MDXH|LUCD (Lucid Diagnostics Inc.) - Debt to Book Capitalization Ratio|Debts to Net Assets prenetics.com PRE|IMDX: Debt to Book Value|Debts to Book Value Trinity Biotech PLC TRIB|PRPH: Debts to Book Capitalization|AIMD - Debt to Book Value|Debts to Book Capitalization Co-Diagnostics, Inc. CODX|heartsciences.com (HSCS) - Debt to Net Assets Ratio|Debts to Book Capitalization BMRA (Biomerica)|Debts to Book Value CDIO|Debt to Book Capitalization Ratio VRAX (Virax Biolabs Group Ltd)|Debt to Book Value Bluejay Diagnostics Corp (BJDX)|AWH: Debts to Book Capitalization|Debts to Book Value acceleratediagnostics.com AXDX|CENTOGENE (CNTG) - Debts to Book Capitalization|ENZ - Debt to Book Value Ratio|fresh2.co - Debts to Book Capitalization|Genetic Technologies Limited (GENE) - Debts to Net Assets|Debts to Book Capitalization ME